| T2D | Type 2 diabetes |
| eGFR | Estimated glomerular filtration rate |
| DKD | Diabetic kidney disease |
| BMI | Body mass index |
| SBP | Systolic blood pressure |
| HbA1c | Glycated hemoglobin concentration |
| LDL | Low-density lipoprotein |
| HDL | High-density lipoprotein |
| ACR | Albumin-to-creatinine ratio |
| NAPCR | Nonalbumin protein-to-creatinine ratio |
| PCR | Urine protein-to-creatinine ratio |
| GPG | Good-prognostic group |
| PPG | Poor-prognostic group |
| LC-MS | Liquid chromatography–mass spectrometry |
| DAP | Differential abundant protein |
| GO | Gene ontology |
| FDR | False discovery rate |
| ROC | Receiver operating characteristic |
| AUC | Area under the receiver operating characteristic curve |
| RF | Random forest |
| SVM | Support vector machine |
| ELISA | Enzyme-linked immunosorbent assay |
| CKD | Chronic kidney disease |
| MS/MS | Tandem mass spectrometry |
| LFQ | Label-free quantitation |
| NSF | Normalization scaling factor |
| DN | Diabetic nephropathy |
| FSGS | Focal and segmental glomerulosclerosis |
| FSGS&MCD | Focal and segmental glomerulosclerosis and minimal change disease |
| HT | Hypertensive nephropathy |
| MCD | Minimal change disease |
| MGN | Membranous glomerulonephritis |
| RPGN | Rapidly progressive glomerulonephritis |
| SLE | Systemic lupus erythematosus |
| TMD | Thin membrane disease |
| TN | Tumor nephrectomies |